Onda, Danise Ann
Yang, Chieh-Hsin https://orcid.org/0000-0003-4360-670X
Goldsmith, Callen
Beddows, Cait A. https://orcid.org/0009-0007-8560-0329
Teo, Rui Qi https://orcid.org/0009-0001-9377-6849
Zhang, Lei
Yuan, XiaoZhuo
Zhu, Yifei
Lee, Man KS
Ovens, Ashley J. https://orcid.org/0000-0001-5711-6555
Yu, Dingyi
Sakamoto, Kei https://orcid.org/0000-0001-8839-5980
Scott, John W. https://orcid.org/0000-0002-1896-9798
Murphy, Andrew J. https://orcid.org/0000-0001-7039-7777
Tsumaki, Noriyuki https://orcid.org/0000-0002-0520-3654
Herzog, Herbert https://orcid.org/0000-0002-1713-1029
Dodd, Garron T. https://orcid.org/0000-0002-7554-4876
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (2019889)
Department of Education and Training | Australian Research Council (FT230100423)
Article History
Received: 24 February 2025
Accepted: 18 May 2026
First Online: 2 June 2026
Competing interests
: The authors declare the following competing interests: K.L. and D.A.O. are inventors on patent applications (PCT/AU2024/050876 and PCT/AU2025/051224), entitled “Methods of Treating Conditions with SIK3 Inhibitors” and “Combination Treatment”, respectively. The remaining authors declare no competing interests.